APR 26, 2018 8:00 AM PDT

Pre-clinical T cell immunotherapy strategies for overcoming immunosuppression in solid tumors

Speaker

Abstract

DATE: April 26, 2018
TIME: 08:00am PDT, 11:00am EDT, 5:00pm CEST

Engineered T cells expressing a tumor antigen-specific receptor have revolutionized the field of cancer therapy for blood cancers. However, similar success has not generally been obtainable in solid tumors, in which the tumor microenvironment (TME) exhibits immunosuppressive effects against injected therapeutic T cells. Our studies have utilized mouse models demonstrated to recapitulate the immunosuppressive features of human cancers to test novel immunotherapy strategies, either alone or in combination. Strategies that incapacitate specific immune-inhibitory pathways operative in the TME can enhance T cell function and improve anti-tumor efficacy. Our results suggest such efforts will soon lead to translation of effective immunotherapies for human solid tumors.

In this webinar, the speaker will:

  • Explain how analysis, including by transcriptome profiling, of appropriate immunocompetent models and human tissues can be used to predict obstacles to therapeutic human T cell function

  • Describe strategies for overcoming immunosuppressive TME features

  • Provide examples in ovarian and pancreatic cancer models of novel T cell engineering that improves the efficacy of adoptive T cell therapy

 

For Research Use Only. Not for use in diagnostic procedures.


Show Resources
You May Also Like
MAY 11, 2021 10:00 AM PDT
C.E. CREDITS
MAY 11, 2021 10:00 AM PDT
Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
JUN 09, 2021 7:00 AM PDT
C.E. CREDITS
JUN 09, 2021 7:00 AM PDT
Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
MAR 18, 2021 8:00 AM PDT
C.E. CREDITS
MAR 18, 2021 8:00 AM PDT
DATE: March 18, 2021 TIME: 8:00am PDT Sequencing of bulk cells, single cells, and nuclei is opening doors in the understanding of complex biological processes....
APR 01, 2021 8:00 AM PDT
C.E. CREDITS
APR 01, 2021 8:00 AM PDT
Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
JUN 03, 2021 12:00 PM CST
JUN 03, 2021 12:00 PM CST
DATE: June 3, 2021 TIME: 12:00pm SGT This webinar is a virtual event that focuses on utilizing the Gibco CTS Rotea System for Cell and Gene Therapy...
JUL 15, 2021 9:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
JUL 15, 2021 9:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Date: July 15, 2021 Time: 9:00am (PDT), 12:00pm (EDT) The Pisces workflow robust, easy-to-use, end-to-end multi-omics solution for highly multiplexed targeted Spatial RNA analysis. VeranomeB...
APR 26, 2018 8:00 AM PDT

Pre-clinical T cell immunotherapy strategies for overcoming immunosuppression in solid tumors


Specialty

Cancer Research

Immunology

Cancer Therapeutics

Immuno-Oncology

Cell Biology

Biotechnology

Molecular Biology

Cancer Diagnostics

Biomarkers

Cell Culture

Antibodies

Biochemistry

Oncology

Gene Expression

Molecular Diagnostics

Geography

North America54%

Europe22%

Asia14%

South America4%

Africa2%

Oceania1%

Registration Source

Website Visitors48%

Email Promotions25%

WAVE Newsletter Promotion17%

Social Media Promotions6%

Client/Sponsor Promotions2%

Trending Newsletter Promotion1%

Website Banners1%

Job Title

Student16%

Scientist14%

Research Scientist13%

Executive11%

Educator/Faculty8%

Facility/Department Manager8%

Medical Laboratory Technician8%

Post Doc7%

Medical Doctor/Specialist6%

Lab Management3%

Clinical Laboratory Scientist3%

Marketing/Sales2%

Biologist1%

Consultant1%

Organization

Academic Institution17%

Biotech Company13%

Research Institute12%

Hospital10%

Pharmaceutical Company7%

Clinical Laboratory6%

Life Science Company4%

Medical Center4%

Government3%

Medical School3%

Non-Profit Organization2%

Contract Research Organization (Cro)2%

Ambulatory Care2%

Consultant2%

Other4%


Show Resources
Loading Comments...
Show Resources
Attendees
  • See more